<p>Vaccinated C57BL/6 mice groups (PBS: n = 4, MT12: n = 4 and MT13: n = 4) were ampicillin-treated (25 mg by gavage), challenged with wild-type SB300 (amp<sup>r</sup>, sm<sup>r</sup>) and euthanized at day 3 post-challenge (p.c.) i.e. day 34 post-vaccination. <b>A:</b> Colonization at various host sites after SB300 challenge. <b>B:</b> Enumeration of cecal pathology in terms of 13 point pathoscore scale was determined as described above (see material and methods). Broken lines in the graphs shows minimum detection limit. n.s.: not significant, *: statistically significant (P<0.05, t-test). <b>C:</b> Representative HE-stained cecum sections obtained from SB300-challenged mice groups immunized with PBS, MT12, MT13. Bar, 200 µm. S, submucosal...
<p><b>A.</b> C57BL/6 mice were subcutaneously vaccinated as previously described (unprimed; white, e...
<p><b>A</b>. Schematic protocol for immunization. <b>B</b>. Parasite recoveries d 28 post-challenge ...
<p>Live vaccine but not killed vaccine controls bacterial loads following secondary challenge. Bacte...
<p>C57BL/6 mice were vaccinated with PBS (n = 4; open symbols), <i>ssaV</i> (5×10<sup>7</sup> cfu; n...
<p>Streptomycin-pretreated C57Bl/6 and <i>Nod2<sup>−/−</sup></i> mice were orally infected with wild...
<p>Vaccination-challenge experiment to analyze the immunogenic potential of <i>S.</i> Typhimurium M1...
<p>Streptomycin-pretreated C57Bl/6, <i>Nod1<sup>−/−</sup></i> and DKO mice were orally infected with...
<p>WT, p19<sup>−/−</sup>(no IL-23), p35<sup>−/−</sup>(no IL-12), and p40<sup>−/−</sup> (no IL-12/-23...
A-C) Wild-type C57BL/6 mice were given an oral gavage of 5×109cfu S. Typhimurium LAV strain BRD509 (...
<p>Bacterial loads in the <b>(A)</b> Peyer’s patches (PP), <b>(B)</b> mesenteric lymph nodes (MLN), ...
Wild-type C57BL/6 (black) or Ifng-/- (pink) mice were i.v. injected with 200cfu TAS2010 (square) or ...
Six weeks after the last vaccination, the mice were challenged by 2 ×106 L. tropica stationary proma...
<p>To identify the attenuation properties of developed <i>Salmonella</i> strains, groups of various ...
<p>(A) Groups of ten C57BL/6 genetically susceptible mice were inoculated orally with 1×10<sup>8</su...
<p>(A) Study design: BALB/c mice were vaccinated intranasally with the pressurized H3N8 at the indic...
<p><b>A.</b> C57BL/6 mice were subcutaneously vaccinated as previously described (unprimed; white, e...
<p><b>A</b>. Schematic protocol for immunization. <b>B</b>. Parasite recoveries d 28 post-challenge ...
<p>Live vaccine but not killed vaccine controls bacterial loads following secondary challenge. Bacte...
<p>C57BL/6 mice were vaccinated with PBS (n = 4; open symbols), <i>ssaV</i> (5×10<sup>7</sup> cfu; n...
<p>Streptomycin-pretreated C57Bl/6 and <i>Nod2<sup>−/−</sup></i> mice were orally infected with wild...
<p>Vaccination-challenge experiment to analyze the immunogenic potential of <i>S.</i> Typhimurium M1...
<p>Streptomycin-pretreated C57Bl/6, <i>Nod1<sup>−/−</sup></i> and DKO mice were orally infected with...
<p>WT, p19<sup>−/−</sup>(no IL-23), p35<sup>−/−</sup>(no IL-12), and p40<sup>−/−</sup> (no IL-12/-23...
A-C) Wild-type C57BL/6 mice were given an oral gavage of 5×109cfu S. Typhimurium LAV strain BRD509 (...
<p>Bacterial loads in the <b>(A)</b> Peyer’s patches (PP), <b>(B)</b> mesenteric lymph nodes (MLN), ...
Wild-type C57BL/6 (black) or Ifng-/- (pink) mice were i.v. injected with 200cfu TAS2010 (square) or ...
Six weeks after the last vaccination, the mice were challenged by 2 ×106 L. tropica stationary proma...
<p>To identify the attenuation properties of developed <i>Salmonella</i> strains, groups of various ...
<p>(A) Groups of ten C57BL/6 genetically susceptible mice were inoculated orally with 1×10<sup>8</su...
<p>(A) Study design: BALB/c mice were vaccinated intranasally with the pressurized H3N8 at the indic...
<p><b>A.</b> C57BL/6 mice were subcutaneously vaccinated as previously described (unprimed; white, e...
<p><b>A</b>. Schematic protocol for immunization. <b>B</b>. Parasite recoveries d 28 post-challenge ...
<p>Live vaccine but not killed vaccine controls bacterial loads following secondary challenge. Bacte...